Guizhou Yibai Pharmaceutical Co Ltd (600594) — Cash Flow Reinvestment Rate
Guizhou Yibai Pharmaceutical Co Ltd (600594) has a Cash Flow Reinvestment Rate of 0.21x as of September 2025, reinvesting CN¥7.08 Million (capex CN¥7.08 Million ) from operating cash flow of CN¥33.28 Million. See Guizhou Yibai Pharmaceutical Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Guizhou Yibai Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2002–2025)
Historical reinvestment intensity for Guizhou Yibai Pharmaceutical Co Ltd across 23 annual periods. For the full cash flow conversion analysis, see Guizhou Yibai Pharmaceutical Co Ltd (600594) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Guizhou Yibai Pharmaceutical Co Ltd (2002–2025)
Year-by-year capital reinvestment analysis for Guizhou Yibai Pharmaceutical Co Ltd. See Guizhou Yibai Pharmaceutical Co Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.14x | CN¥35.08 Million | CN¥256.71 Million | CN¥34.99 Million | ▼ -89.8% |
| 2024 | 1.34x | CN¥116.31 Million | CN¥86.87 Million | CN¥96.32 Million | ▲ +286.6% |
| 2023 | 0.35x | CN¥130.78 Million | CN¥377.61 Million | CN¥130.38 Million | ▼ -65.1% |
| 2022 | 0.99x | CN¥342.92 Million | CN¥345.30 Million | CN¥322.92 Million | ▲ +69.2% |
| 2021 | 0.59x | CN¥548.48 Million | CN¥934.21 Million | CN¥447.78 Million | ▼ -56.5% |
| 2020 | 1.35x | CN¥494.68 Million | CN¥366.66 Million | CN¥395.74 Million | ▲ +142.1% |
| 2019 | 0.56x | CN¥202.17 Million | CN¥362.71 Million | CN¥201.28 Million | ▼ -62.9% |
| 2018 | 1.50x | CN¥322.01 Million | CN¥214.30 Million | CN¥321.33 Million | ▲ +124.1% |
| 2017 | 0.67x | CN¥457.21 Million | CN¥681.78 Million | CN¥402.80 Million | ▼ -31.6% |
| 2016 | 0.98x | CN¥373.22 Million | CN¥380.62 Million | CN¥332.53 Million | ▲ +95.3% |
| 2015 | 0.50x | CN¥288.02 Million | CN¥573.68 Million | CN¥288.02 Million | ▲ +33.3% |
| 2014 | 0.38x | CN¥203.94 Million | CN¥541.58 Million | CN¥203.94 Million | ▼ -20.5% |
| 2013 | 0.47x | CN¥273.48 Million | CN¥577.24 Million | CN¥273.48 Million | ▼ -34.9% |
| 2012 | 0.73x | CN¥209.64 Million | CN¥288.01 Million | CN¥209.64 Million | ▲ +42.1% |
| 2011 | 0.51x | CN¥142.34 Million | CN¥277.83 Million | CN¥142.34 Million | ▲ +19.3% |
| 2010 | 0.43x | CN¥49.66 Million | CN¥115.66 Million | CN¥49.66 Million | ▼ -0.1% |
| 2009 | 0.43x | CN¥44.62 Million | CN¥103.88 Million | CN¥44.62 Million | ▲ +29.3% |
| 2008 | 0.33x | CN¥62.86 Million | CN¥189.26 Million | CN¥62.86 Million | ▼ -89.8% |
| 2007 | 3.26x | CN¥38.97 Million | CN¥11.94 Million | CN¥38.97 Million | ▲ +1738.0% |
| 2006 | 0.18x | CN¥17.00 Million | CN¥95.77 Million | CN¥17.00 Million | ▼ -96.2% |
| 2005 | 4.66x | CN¥80.99 Million | CN¥17.38 Million | CN¥80.99 Million | ▲ +153.2% |
| 2003 | 1.84x | CN¥169.47 Million | CN¥92.10 Million | CN¥169.47 Million | ▲ +501.0% |
| 2002 | 0.31x | CN¥22.49 Million | CN¥73.46 Million | CN¥22.49 Million | — |